Matthew Solitro MD in Burlington, New Jersey

Medical School: University Of Pittsburgh School Of Medicine
Graduation Year: 2001
The Primary Medical Specialty for Matthew Solitro MD is listed as: Nephrology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 23
PAC (PECOS ID)#: 7911004254
NPI #: 1306870555
NPI Created On: 07/11/2006
NPI Last Updated Listed as: 03/07/2023
Primary Taxonomy Code: 207RN0300X
License Number:
MA 80656
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• AmeriHealth New Jersey
• Blue Cross Blue Shield
• Humana
• Oscar Garden State Insurance Corporation
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

1. Manual urinalysis test with examination using microscope
2. Creatinine level to test for kidney function or muscle injury
3. Hemoglobin measurement
4. Hemodialysis procedure with one physician evaluation
5. Dialysis procedure including one evaluation
6. Dialysis services (4 or more physician visits per month), patient 20 years of age and older
7. Dialysis services (2-3 physician visits per month), patient 20 years of age and older
8. Home dialysis services per month, patient 20 years of age or older
9. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
10. New patient office or other outpatient visit, typically 45 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Established patient office or other outpatient, visit typically 40 minutes
14. Initial hospital inpatient care, typically 50 minutes per day
15. Initial hospital inpatient care, typically 70 minutes per day
16. Subsequent hospital inpatient care, typically 25 minutes per day
17. Subsequent hospital inpatient care, typically 35 minutes per day
18. Critical care delivery critically ill or injured patient, first 30-74 minutes
19. Injection, darbepoetin alfa, 1 microgram (non-esrd use)